US5648084A
(en)
*
|
1990-02-28 |
1997-07-15 |
Guttag; Alvin |
Multiple dosage medicine drop bottle
|
US5472954A
(en)
*
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
US5684169A
(en)
*
|
1992-11-27 |
1997-11-04 |
Ensuiko Sugar Refining Co., Ltd. |
Cyclodextrin inclusion complex of taxol, and method for its production and its use
|
US5494901A
(en)
*
|
1993-01-05 |
1996-02-27 |
Javitt; Jonathan C. |
Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
|
TW256831B
(da)
*
|
1993-04-22 |
1995-09-11 |
Senju Pharma Co |
|
WO1995005199A1
(en)
*
|
1993-08-19 |
1995-02-23 |
Dextran Products Limited |
Pharmaceutical preparation and a process for making same
|
SI9300470A
(en)
*
|
1993-09-10 |
1995-04-30 |
Lek Tovarna Farmacevtskih |
Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
|
US6395744B1
(en)
|
1994-04-22 |
2002-05-28 |
Queen's University At Kingston |
Method and compositions for the treatment or amelioration of female sexual dysfunction
|
JP3310982B2
(ja)
|
1994-04-22 |
2002-08-05 |
ペンテツク・フアーマシユーテイカルズ・インコーポレイテツド |
男性の勃起機能不全を改善するための剤形及び方法
|
US6121276A
(en)
*
|
1994-04-22 |
2000-09-19 |
Pentech Pharmaceuticals, Inc. |
Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
|
US5683709A
(en)
*
|
1994-05-05 |
1997-11-04 |
Ciba Vision Corporation |
Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
|
TW438601B
(en)
*
|
1994-05-18 |
2001-06-07 |
Janssen Pharmaceutica Nv |
New mucoadhesive emulsion compositions and a process for the preparation thereof
|
GB2290964A
(en)
*
|
1994-07-08 |
1996-01-17 |
Arto Olavi Urtti |
Transdermal drug delivery system
|
US5525596A
(en)
*
|
1994-10-21 |
1996-06-11 |
Merck & Co., Inc. |
Absorption enhancer/solubilizer combination for improved bioavailability of a zwitterionic compound
|
US5679573A
(en)
*
|
1995-07-27 |
1997-10-21 |
Abbott Laboratories |
Stabilized aqueous steroid immunoassay standards with cyclodextrins
|
FR2738149B1
(fr)
*
|
1995-09-06 |
1997-11-14 |
Chauvin Lab Sa |
Collyre a base d'indometacine pret a l'emploi
|
US5744154A
(en)
*
|
1995-09-06 |
1998-04-28 |
Laboratoire Chauvin S.A. |
Ready-to-use indomethacin-based eye lotion
|
JP2920611B2
(ja)
*
|
1995-12-11 |
1999-07-19 |
株式会社シーエーシー |
皮膚炎の治療外用剤
|
US5773031A
(en)
*
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
WO1997039761A1
(en)
|
1996-04-19 |
1997-10-30 |
Alpha Therapeutic Corporation |
A process for viral inactivation of lyophilized blood proteins
|
US5906981A
(en)
*
|
1996-06-04 |
1999-05-25 |
Troy Corporation |
Halopropargyl inclusion complexes
|
DE69800357T2
(de)
*
|
1997-03-11 |
2001-05-17 |
Hexal Ag |
Feste, nicht zerfliessbare formulierung von natrium valproat
|
DE19713092A1
(de)
*
|
1997-03-27 |
1998-10-01 |
Wacker Chemie Gmbh |
Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung
|
GB9712269D0
(en)
*
|
1997-06-12 |
1997-08-13 |
Procter & Gamble |
Cosmetic composition
|
GB9712272D0
(en)
*
|
1997-06-12 |
1997-08-13 |
Procter & Gamble |
Cosmetic composition
|
US6316010B2
(en)
|
1997-06-12 |
2001-11-13 |
The Procter & Gamble Company |
Cosmetic compositions
|
US6537537B2
(en)
|
1997-06-12 |
2003-03-25 |
The Procter & Gamble Company |
Water-in-silicone emulsion cosmetic compositions
|
GB9712271D0
(en)
*
|
1997-06-12 |
1997-08-13 |
Procter & Gamble |
Cosmetic composition
|
PT986403E
(pt)
*
|
1997-06-13 |
2004-04-30 |
Cydex Inc |
Composicao com um tempo de vida de armazenagem prolongado compreendendo a ciclodextrina e drogas ou prodrogas que se decompoem em compostos insoluveis em agua
|
US6699849B1
(en)
|
1998-02-23 |
2004-03-02 |
Cyclops, Ehf. |
Cyclodextrin complexes of benzodiazepines
|
WO1999042111A1
(en)
*
|
1998-02-23 |
1999-08-26 |
Cyclops, Ehf. |
High-energy cyclodextrin complexes
|
US6403605B1
(en)
|
1998-05-29 |
2002-06-11 |
Queen's University At Kingston |
Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
|
NZ330726A
(en)
*
|
1998-06-18 |
2000-10-27 |
Dec Res |
Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
|
US20020198174A1
(en)
*
|
2001-05-07 |
2002-12-26 |
Allergan Sales, Inc. |
Disinfecting and solubilizing steroid compositions
|
EP1109581A1
(en)
*
|
1998-09-02 |
2001-06-27 |
Allergan Sales, Inc. |
Preserved cyclodextrin-containing compositions
|
GB9822681D0
(en)
*
|
1998-10-16 |
1998-12-09 |
Vitabiotics Ltd |
Method of treatment
|
UA74141C2
(uk)
|
1998-12-09 |
2005-11-15 |
Дж.Д. Сірл Енд Ко. |
Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
|
US6290946B1
(en)
|
1999-05-13 |
2001-09-18 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as toxin binders and antibacterial agents
|
US6270755B1
(en)
*
|
1999-05-13 |
2001-08-07 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as toxin binders
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
WO2001001955A1
(en)
*
|
1999-07-02 |
2001-01-11 |
Janssen Pharmaceutica N.V. |
Nasal formulation of an antifungal
|
US7069226B1
(en)
|
1999-07-07 |
2006-06-27 |
Synetic, Incorporated |
Prescription data processing system for determining new therapy starts
|
AUPQ633900A0
(en)
*
|
2000-03-20 |
2000-04-15 |
Jurox Pty Ltd |
Anaesthetic composition
|
CA2314494A1
(en)
|
2000-05-02 |
2001-11-02 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as species specific antibacterial agents
|
AU2001259306A1
(en)
*
|
2000-05-02 |
2001-11-12 |
Advanced Medicine, Inc. |
Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
|
SG98393A1
(en)
|
2000-05-19 |
2003-09-19 |
Inst Materials Research & Eng |
Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
|
FR2809311A1
(fr)
*
|
2000-05-23 |
2001-11-30 |
Chauvin Lab Sa |
Solution ophtalmique a base d'acetazolamide destinee au traitement du glaucome
|
US6468989B1
(en)
*
|
2000-07-13 |
2002-10-22 |
Dow Pharmaceutical Sciences |
Gel compositions containing metronidazole
|
PE20020300A1
(es)
*
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
GB0027180D0
(en)
*
|
2000-11-07 |
2000-12-27 |
Unilever Plc |
Cosmetic and personal care compositions
|
ME00293B
(me)
*
|
2000-12-20 |
2011-05-10 |
Bayer Ip Gmbh |
Sastavi estrogen-ciklodekstrin kompleksa
|
EP1216713A1
(en)
*
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
US20020146409A1
(en)
*
|
2001-01-30 |
2002-10-10 |
Herring Steven W. |
Methods for stabilizing lyophilized blood proteins
|
US20030064103A1
(en)
*
|
2001-05-01 |
2003-04-03 |
Lin Shun Y. |
Compositions and methods for treating vulvovaginitis and vaginosis
|
US20060172007A1
(en)
*
|
2001-05-01 |
2006-08-03 |
Nawaz Ahmad |
Compositions and methods for reducing vaginal pH
|
US20030017207A1
(en)
*
|
2001-05-01 |
2003-01-23 |
Lin Shun Y. |
Compositions and methods for treating vulvovaginitis and vaginosis
|
US20040214797A1
(en)
*
|
2001-05-07 |
2004-10-28 |
Allergan, Inc. |
Preserved pharmaceutical compositions comprising cyclodextrins
|
EP1443969A2
(en)
*
|
2001-10-18 |
2004-08-11 |
Decode Genetics EHF |
Non-inclusion cyclodextrin complexes
|
KR20030041577A
(ko)
*
|
2001-11-20 |
2003-05-27 |
디디에스텍주식회사 |
난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
|
US6881726B2
(en)
*
|
2001-12-24 |
2005-04-19 |
Dow Pharmaceutical Sciences |
Aqueous compositions containing metronidazole
|
EP1323432B1
(en)
*
|
2001-12-28 |
2005-08-24 |
Sandra Cosci |
Complexes of cyclodextrins with potassium ion homeostasis regulators
|
US20090215735A1
(en)
*
|
2002-02-25 |
2009-08-27 |
Alcon, Inc. |
Topical solution formulations containing a corticosteroid and a cyclodextrin
|
DE10211192A1
(de)
*
|
2002-03-14 |
2003-09-25 |
Beiersdorf Ag |
Isoflavanoide gegen Hautalterung und Akne
|
US20060105008A1
(en)
*
|
2002-03-28 |
2006-05-18 |
Nawaz Ahmad |
Compositions and methods for reducing vaginal pH
|
RU2321597C2
(ru)
*
|
2002-04-19 |
2008-04-10 |
Новартис Аг |
Биоматериал, способ его приготовления и его применение, медицинское средство, имплантат и вкладыш
|
US6824763B2
(en)
|
2002-05-30 |
2004-11-30 |
Kimberly-Clark Worldwide, Inc. |
Anti-fungal powder having enhanced excipient properties
|
US7297348B2
(en)
*
|
2002-07-19 |
2007-11-20 |
Omeros Corporation |
Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
|
KR20050030208A
(ko)
*
|
2002-07-22 |
2005-03-29 |
젠자임 코포레이션 |
폴리(칼륨 및 나트륨 스티렌 설포네이트), 이의 제조방법및 용도
|
EP2292762A3
(en)
*
|
2002-12-20 |
2012-12-12 |
Board of Regents, The University of Texas System |
VMP-like sequences of pathogenic Borrelia species and strains
|
DE10260872B4
(de)
|
2002-12-23 |
2013-09-26 |
Beiersdorf Ag |
Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
|
DE10260873A1
(de)
*
|
2002-12-23 |
2004-07-15 |
Beiersdorf Ag |
Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
|
US7993654B2
(en)
*
|
2002-12-23 |
2011-08-09 |
Beiersdorf Ag |
Self-adhesive polymer matrix containing sea algae extract
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
CN100584385C
(zh)
*
|
2003-07-10 |
2010-01-27 |
协和发酵生化株式会社 |
片剂及其制备方法
|
CA2530352A1
(en)
*
|
2003-07-24 |
2005-02-03 |
Astellas Pharma Inc. |
Quinolone derivative or salt thereof
|
US20050065062A1
(en)
*
|
2003-09-24 |
2005-03-24 |
3M Innovative Properties Company |
Method of formulating a pharmaceutical composition
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
MX348041B
(es)
|
2003-12-31 |
2017-05-25 |
Cydex Pharmaceuticals Inc |
Formulación inhalante que contiene éter sulfoalquilico-ciclodextri na y un corticosteroide.
|
AU2005209201B2
(en)
|
2004-01-20 |
2010-06-03 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
US20050234018A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
ES2717248T3
(es)
|
2004-04-23 |
2019-06-20 |
Cydex Pharmaceuticals Inc |
Formulación de DPI que contiene sulfoalquil éter ciclodextrina
|
WO2005110374A1
(en)
*
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US8147865B2
(en)
*
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20050272700A1
(en)
*
|
2004-05-10 |
2005-12-08 |
Servet Buyuktimkin |
Topical treatment and prevention of human papilloma virus (HPV) infection
|
EP1773350B1
(en)
*
|
2004-07-12 |
2013-05-29 |
Allergan, Inc. |
Opthalmic compositions for treating ophthalmic conditions
|
WO2006011044A1
(en)
*
|
2004-07-22 |
2006-02-02 |
Pfizer Products Inc. |
Amorphous cyclodextrin compositions
|
ES2369554T3
(es)
*
|
2004-09-24 |
2011-12-01 |
Rfe Pharma Llc |
Carboxi-amido-triazoles para el tratamiento local de enfermedades oculares.
|
MX2007003718A
(es)
*
|
2004-09-27 |
2007-04-23 |
Cargill Inc |
Complejos de inclusion de ciclodextrina y metodos para preparar los mismos.
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20060093675A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Mathew Ebmeier |
Intravaginal treatment of vaginal infections with metronidazole compositions
|
US8296162B1
(en)
|
2005-02-01 |
2012-10-23 |
Webmd Llc. |
Systems, devices, and methods for providing healthcare information
|
WO2006137959A1
(en)
*
|
2005-06-13 |
2006-12-28 |
Cargill, Incorporated |
Cyclodextrin inclusion complexes and methods of preparing same
|
US20090029020A1
(en)
*
|
2005-06-13 |
2009-01-29 |
Cargill, Incorporated |
Cyclodextrin inclusion complexes and methods of preparing same
|
US20080003296A1
(en)
*
|
2005-07-11 |
2008-01-03 |
Ketner Rodney J |
Amorphous Cyclodextrin Compositions
|
US7893040B2
(en)
|
2005-07-22 |
2011-02-22 |
Oculis Ehf |
Cyclodextrin nanotechnology for ophthalmic drug delivery
|
WO2007047253A2
(en)
*
|
2005-10-11 |
2007-04-26 |
Eastman Chemical Company |
Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
|
MX348982B
(es)
|
2005-10-26 |
2017-07-06 |
Cydex Pharmaceuticals Inc |
Composiciones de eter sulfoalquilico-ciclodextrina y metodos de preparacion de las mismas.
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
US20070238789A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Chin-Ming Chang |
Prednisolone acetate compositions
|
CA2654799A1
(en)
*
|
2006-06-13 |
2007-12-21 |
Cargill, Incorporated |
Large-particle cyclodextrin inclusion complexes and methods of preparing same
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
US8115005B2
(en)
|
2006-08-04 |
2012-02-14 |
Decode Genetics Ehf. |
Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
|
US7728032B2
(en)
*
|
2006-08-04 |
2010-06-01 |
Decode Genetics Ehf |
Phenoxymethylalkyne inhibitors of LTA4H for treating inflammation
|
EP2066800A2
(en)
*
|
2006-08-04 |
2009-06-10 |
Decode Genetics EHF |
Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation
|
US9039761B2
(en)
|
2006-08-04 |
2015-05-26 |
Allergan, Inc. |
Ocular implant delivery assemblies with distal caps
|
MX2009007084A
(es)
*
|
2006-12-27 |
2009-08-20 |
Cargill Inc |
Complejos de inclusion de ciclodextrina y metodos para preparar los mismos.
|
US8380530B2
(en)
|
2007-02-02 |
2013-02-19 |
Webmd Llc. |
Personalized health records with associative relationships
|
CA2679919C
(en)
*
|
2007-03-02 |
2015-12-15 |
University Of Wollongong |
Compositions and methods for delivery of anti-cancer agents
|
EP2152078B8
(en)
|
2007-04-27 |
2021-03-17 |
CyDex Pharmaceuticals, Inc. |
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
|
US20080283693A1
(en)
*
|
2007-05-15 |
2008-11-20 |
Evans Michael J F |
Propulsion apparatus and system
|
EP2178522A1
(en)
*
|
2007-07-11 |
2010-04-28 |
Fertin Pharma A/S |
Compressed chewing gum tablet comprising taste-masking agent
|
WO2009006898A1
(en)
*
|
2007-07-11 |
2009-01-15 |
Fertin Pharma A/S |
Stable medicated chewing gum comprising cyclodextrin inclusion complex
|
US7635773B2
(en)
|
2008-04-28 |
2009-12-22 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions
|
WO2010047831A1
(en)
*
|
2008-10-23 |
2010-04-29 |
Nycomed Us Inc. |
Stable metronidazole gel formulations
|
WO2010053487A1
(en)
|
2008-11-07 |
2010-05-14 |
Cydex Pharmaceuticals, Inc. |
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
US8545554B2
(en)
*
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
HUE047755T2
(hu)
|
2009-05-13 |
2020-05-28 |
Cydex Pharmaceuticals Inc |
Prasugrelt és ciklodextrin-származékokat tartalmazó gyógyszerkészítmények, eljárás ezek elõállítására és alkalmazásra
|
PL2434886T3
(pl)
|
2009-05-29 |
2020-05-18 |
Cydex Pharmaceuticals, Inc. |
Kompozycje do wstrzykiwania melfalanu zawierające pochodną cyklodekstryny i sposoby ich wytwarzania i stosowania
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
US8658129B2
(en)
*
|
2009-06-04 |
2014-02-25 |
General Electric Company |
Agents and methods for the imaging of myelin basic protein
|
US8859003B2
(en)
|
2009-06-05 |
2014-10-14 |
Intercontinental Great Brands Llc |
Preparation of an enteric release system
|
US9968564B2
(en)
|
2009-06-05 |
2018-05-15 |
Intercontinental Great Brands Llc |
Delivery of functional compounds
|
US20100310726A1
(en)
|
2009-06-05 |
2010-12-09 |
Kraft Foods Global Brands Llc |
Novel Preparation of an Enteric Release System
|
HUP0900698A2
(en)
|
2009-11-06 |
2011-06-28 |
Richter Gedeon Nyrt |
Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation
|
US10328152B2
(en)
|
2011-06-16 |
2019-06-25 |
Nayan Patel |
Method for stabilization and delivery of therapeutic molecules
|
HUE058834T2
(hu)
|
2012-02-15 |
2022-09-28 |
Cydex Pharmaceuticals Inc |
Elõállítási eljárás ciklodextrin-származékokhoz
|
KR101633479B1
(ko)
|
2012-02-28 |
2016-07-08 |
사이덱스 파마슈티칼스, 인크. |
알킬화된 시클로덱스트린 조성물 및 이의 제조 및 사용 방법
|
US9409901B2
(en)
|
2012-10-22 |
2016-08-09 |
Bantam Pharmaceutical, Llc |
Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E
|
EP2909239A4
(en)
|
2012-10-22 |
2016-06-08 |
Cydex Pharmaceuticals Inc |
ALKYLATED CYCLODEXTRIN COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
|
US8859005B2
(en)
|
2012-12-03 |
2014-10-14 |
Intercontinental Great Brands Llc |
Enteric delivery of functional ingredients suitable for hot comestible applications
|
AU2014277952A1
(en)
|
2013-06-13 |
2016-01-28 |
Veroscience Llc |
Compositions and methods for treating metabolic disorders
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
PT3183295T
(pt)
|
2014-08-22 |
2023-11-03 |
Cydex Pharmaceuticals Inc |
Composições de ciclodextrina alquilada fracionada e processos para preparação e utilização das mesmas
|
CA3018328A1
(en)
|
2014-10-31 |
2016-04-30 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
DE202016100357U1
(de)
*
|
2016-01-27 |
2016-03-09 |
Peter Sommer |
Pharmazeutische Zubereitung und deren Verwendung bei viralen, entzündlichen Erkrankungen der oberen Atemwege
|
US10722498B2
(en)
|
2017-01-27 |
2020-07-28 |
Shilpa Medicare Limited |
Acetazolamide ophthalmic solution
|
EP3675819A1
(en)
*
|
2017-08-29 |
2020-07-08 |
Fresenius Kabi Oncology Limited |
Stable liquid compositions of pemetrexed
|
CR20210258A
(es)
*
|
2018-10-24 |
2021-06-21 |
Adama Makhteshim Ltd |
Uso de ciclodextrinas como sistema de suministro de productos agroquímicos
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
US20230233572A1
(en)
|
2020-06-11 |
2023-07-27 |
Sentiss Pharma Private Limited |
Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent
|